Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2022 | Aurora A kinase inhibition with VIC-1911 potentiates KRASG12Ci and overcomes resistance

Previously, Aurora A Kinase (ARUKA) has been shown to mediate adaptive resistance to KRASG12C inhibitors, and synergistic antitumor effects have been demonstrated when combining inhibition of the mitotic cell regulator, WEE1, with ARUKA inhibition. Jong Woo Lee, MD, PhD, Yale Cancer Center and Yale University School of Medicine, New Haven, CT, discusses a preclinical study into the inhibition of ARUKA with VIC-1911 on resistance to sotorasib in lung cancer. The antitumor effect of combining VIC-1911 with a WEE1 inhibitor, adavosertib, was also explored. Findings from the investigation linked ARUKA activation to both intrinsic and acquired resistance to sotorasib in KRASG12C-mutated lung cancer and show antitumor activity for AURKA inhibition in these settings. Thus, combining ARUKA with sotorasib inhibition may be a promising therapeutic approach to overcoming intrinsic resistance to KRASG12C inhibitors in lung cancer. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.